Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,754,000 | 1,250,000 | 879,000 | 1,004,000 | 1,071,000 |
| Marketable Securities | 1,149,000 | 1,243,000 | 1,224,000 | 1,189,000 | 1,213,000 |
| Receivables | 1,692,000 | 1,666,000 | 1,439,000 | 1,226,000 | 1,134,000 |
| Inventories | 1,297,000 | 1,178,000 | 1,063,000 | 909,000 | 804,000 |
| Income taxes - deferred | 293,000 | 278,000 | N/A | N/A | N/A |
| TOTAL | $6,285,000 | $5,704,000 | $4,905,000 | $4,611,000 | $4,533,000 |
| Non-Current Assets | |||||
| PPE Net | 4,353,000 | 4,173,000 | 4,047,000 | 3,760,000 | 3,565,000 |
| Investments And Advances | 1,889,000 | 1,832,000 | 1,787,000 | 1,734,000 | 1,658,000 |
| Intangibles | 1,764,000 | 1,791,000 | 1,814,000 | 1,838,000 | 1,863,000 |
| Other Non-Current Assets | 1,397,000 | 1,342,000 | 1,299,000 | 1,241,000 | 1,093,000 |
| TOTAL | $9,403,000 | $9,138,000 | $8,947,000 | $8,573,000 | $8,179,000 |
| Total Assets | $15,688,000 | $14,842,000 | $13,852,000 | $13,184,000 | $12,712,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 420,000 | 346,000 | 279,000 | 279,000 | 328,000 |
| Other current liabilities | N/A | N/A | 1,394,000 | 1,303,000 | 1,059,000 |
| TOTAL | $2,078,000 | $2,010,000 | $1,805,000 | $1,779,000 | $1,750,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,267,000 | 2,204,000 | 2,164,000 | 2,132,000 | 2,103,000 |
| Deferred Revenues | 57,000 | 62,000 | 42,000 | 47,000 | 45,000 |
| Other Non-Current Liabilities | 1,006,000 | 951,000 | 784,000 | 774,000 | 736,000 |
| TOTAL | $3,462,000 | $3,354,000 | $3,157,000 | $3,125,000 | $3,068,000 |
| Total Liabilities | $5,540,000 | $5,364,000 | $4,962,000 | $4,904,000 | $4,818,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,053,170 | 1,053,186 | 1,054,001 | 1,052,956 | 1,053,627 |
| Common Shares | 21,000 | 21,000 | 21,000 | 21,000 | 21,000 |
| Retained earnings | -507,000 | -838,000 | -1,222,000 | -1,597,000 | -1,850,000 |
| Other shareholders' equity | 212,000 | 204,000 | 210,000 | 193,000 | 255,000 |
| TOTAL | $10,148,000 | $9,478,000 | $8,890,000 | $8,280,000 | $7,894,000 |
| Total Liabilities And Equity | $15,688,000 | $14,842,000 | $13,852,000 | $13,184,000 | $12,712,000 |